Phase
Condition
Colon Cancer
Colorectal Cancer
Rectal Cancer
Treatment
Placebo
Rifaximin
Clinical Study ID
Ages > 21 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with a history of rectal cancer treated with an anterior resectionpreformed at MSKCC (tumor at or below 12cm from anal verge) with restoration ofbowel continuity ≥1 and ≤ 5 years. (Patients may also have had procedures toconstruct neo-rectums including j-pouch, coloplasty, and end to side anastomosis).
Patients ≥ 21 years of age.
Presence of anterior resection symptoms by patients own assessment. These symptomsmay include any of the following: incomplete evacuation, clustering of bowelmotions, frequency of bowel motions, unformed stool, excessive flatus, orincontinence of flatus and/or feces.
Exclusion
Exclusion Criteria:
Local recurrence of rectal cancer.
Antibiotic treatment within the last 4 weeks for any condition.
Pregnancy or breast feeding.
Study Design
Connect with a study center
Memorial Sloan Kettering Cancer Center at Basking Ridge
Basking Ridge, New Jersey
United StatesSite Not Available
Memorial Sloan Kettering Cancer Center Commack
Commack, New York 11725
United StatesSite Not Available
Memorial Sloan Kettering Cancer Center
New York, New York 10065
United StatesSite Not Available
Memorial Sloan Kettering Cancer Center Sleepy Hollow
Sleepy Hollow, New York 10591
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.